EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

Real‐World Medication Adherence and Medication Reviews in Adults and Children With Cystic Fibrosis

Lieke Roeke iD, Liesbeth I van de Ven iD, Steffie E M Vonk iD, Jan J M Coremans, Edward Dompeling, Michiel A G E Bannier iD, Fatma Karapinar-Çarkit iD, Judith de Ruijter-van Dalem iD

Pediatric Pulmonology · 2026

DOI: 10.1002/ppul.71815 ↗

At a glance

Journal article in Pediatric Pulmonology, 2026. Written by Lieke Roeke and 7 co-authors. Institution: Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre+, Maastricht, the Netherlands. Major MEDLINE topics: Cystic Fibrosis, Drug Monitoring, Medication Adherence. 30 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

People with cystic fibrosis (pwCF) have complex treatment regimens with cystic fibrosis transmembrane conductance regulator (CFTR) modulators and supportive therapies. Evidence on adherence across cystic fibrosis (CF) therapies using different assessment methods and the added value of medication reviews remains limited. Objective(s) This study compared adherence across CF therapies using three assessment methods and evaluated the contribution of medication reviews.

Methods

This cross‐sectional study (February to April 2025) included pediatric and adult pwCF at Maastricht University Medical Centre+. Adherence to CFTR modulators and supportive therapies (vitamin supplements, pancreatic enzymes, inhalers, and nebulizers) was assessed with pharmacy refill data (medication possession ratio, MPR); self‐reported adherence (Medication Adherence Report Scale‐5, MARS‐5), and structured medication reviews. The primary outcome was the proportion of pwCF adherent to CF medication per assessment method. Secondary outcomes were the within‐patient differences in adherence between CFTR and supportive therapies (McNemar's exact test) based on MPR and the number and acceptance of DRP‐interventions in the medication review.

Results

Forty‐three pwCF (17 children, 26 adults; 39.5% female) were included. For CFTR modulators, adherence was 91.7% (MPR), 91.2% (MARS‐5), and 72.2% (medication review). For supportive therapies, adherence was 56.3%, 77.7%, and 77.4%, respectively. Four nonadherent pwCF were identified exclusively through medication review. Within‐patients, adherence was higher for CFTR modulators than for supportive therapies ( p < 0.001). Medication reviews identified 51 DRPs in 41 pwCF (including nonadherence in 12 pwCF), all proposed interventions were accepted by the treating physician.

Conclusion

Adherence varied by medication class and assessment method. Medication reviews provided clinically relevant information in addition to refill‐based and self‐reported measures.

Subjects

MeSH terms (MEDLINE)

Cystic FibrosisDrug MonitoringMedication AdherenceHumansFemaleCross-Sectional StudiesChildMaleAdultAdolescentCystic Fibrosis Transmembrane Conductance RegulatorYoung AdultAdherence InterventionsNetherlandsMiddle AgedChild, Preschool

Author keywords

CFTR modulatorscystic fibrosismedication adherencemedication reviewreal‐world data

Substances

Cystic Fibrosis Transmembrane Conductance Regulator

Authors and institutions

  • Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre+, Maastricht, the Netherlands.
  • Department of Clinical Pharmacy, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.
  • Department of Paediatric Respiratory Medicine, School for Public Health and Primary Care (CAPHRI), MosaKids Children's Hospital, and Maastricht University Medical Centre+, Maastricht, the Netherlands.
  • Department of Clinical Pharmacy, Institute of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Maastricht, the Netherlands.

ORCID profiles: Lieke Roeke, Liesbeth I van de Ven, Steffie E M Vonk, Michiel A G E Bannier, Fatma Karapinar-Çarkit, Judith de Ruijter-van Dalem

Cite

APA

Roeke, L., van de Ven, L. I., Vonk, S. E. M., Coremans, J. J. M., Dompeling, E., Bannier, M. A. G. E., Karapinar-Çarkit, F., & Dalem, J. R. (2026). Real‐World Medication Adherence and Medication Reviews in Adults and Children With Cystic Fibrosis. Pediatric Pulmonology. https://doi.org/10.1002/ppul.71815

Vancouver

Roeke L, van de Ven LI, Vonk SEM, Coremans JJM, Dompeling E, Bannier MAGE, et al. Real‐World Medication Adherence and Medication Reviews in Adults and Children With Cystic Fibrosis. Pediatric Pulmonology. 2026. doi:10.1002/ppul.71815

BibTeX
@article{Roeke2026,
  author = {Roeke, Lieke and van de Ven, Liesbeth I and Vonk, Steffie E M and Coremans, Jan J M and Dompeling, Edward and Bannier, Michiel A G E and Karapinar-Çarkit, Fatma and Dalem, Judith de Ruijter-van},
  title = {Real‐World Medication Adherence and Medication Reviews in Adults and Children With Cystic Fibrosis},
  journal = {Pediatric Pulmonology},
  year = {2026},
  doi = {10.1002/ppul.71815}
}
Start for free →